GBC seeks nominations for fourth annual Bioscience Awards

bioawards09-2sq1

The Greater Baltimore Committee is seeking nominations for the Fourth Annual Bioscience Awards to be held on March 12. Nominate a company or individual you know for an award. 

The four award categories are: Entrepreneurial, Best New Product or Progress, Leadership in Bioscience, and President’s Award. Nominators will be asked to submit documentation and narratives that fulfill several criteria and then to add other supporting evidence as deemed suitable. Self-nominations are accepted and encouraged. Nominations will close on March 2.

“It’s important to recognize our growing bioscience industry that will play a major role in the state’s economic future,” said Donald C. Fry, president and CEO of the Greater Baltimore Committee. “The bioscience companies in Maryland are doing some amazing things and demonstrating that they are leaders in their field.”

Judges for the awards are: Scott Allocco, president, BioMarker Strategies; Judy Britz, principal, Britz Consulting; David J. Fink, Ph.D., Biotech Entrepreneur-in-Residence, techcenter@UMBC; Elizabeth Good Mazhari, director, Strategic Investments, University of Maryland, Baltimore; Mark E. Rapson, CPA, Shareholder, Board of Directors, Katz Abosch; Howard S. Schwartz, partner, DLA Piper; and Paul Silber, Ph.D., biotechnology investor.

Program sponsor for the event is DLA Piper.  Patron sponsor is Katz Abosch. Media sponsor is The Daily Record.

For more information, contact GBC vice president Lisbeth Pettengill at 410-727-2820.

Register to attend the event. 

Comments are closed.